Kuangli Bio-Tech Holdings Balance Sheet Health
Financial Health criteria checks 2/6
Kuangli Bio-Tech Holdings has a total shareholder equity of NT$526.4M and total debt of NT$178.0M, which brings its debt-to-equity ratio to 33.8%. Its total assets and total liabilities are NT$971.2M and NT$444.8M respectively.
Key information
33.8%
Debt to equity ratio
NT$178.01m
Debt
Interest coverage ratio | n/a |
Cash | NT$78.67m |
Equity | NT$526.39m |
Total liabilities | NT$444.81m |
Total assets | NT$971.20m |
Recent financial health updates
We're Not Worried About Kuangli Photoelectric Technology's (TPE:6431) Cash Burn
Mar 31We Think Kuangli Photoelectric Technology (TPE:6431) Can Easily Afford To Drive Business Growth
Dec 09Recent updates
Kuangli Bio-Tech Holdings Co., Ltd.'s (TWSE:6431) Shareholders Might Be Looking For Exit
Mar 22We're Not Worried About Kuangli Photoelectric Technology's (TPE:6431) Cash Burn
Mar 31Did Business Growth Power Kuangli Photoelectric Technology's (TPE:6431) Share Price Gain of 248%?
Feb 03We Think Kuangli Photoelectric Technology (TPE:6431) Can Easily Afford To Drive Business Growth
Dec 09Financial Position Analysis
Short Term Liabilities: 6431's short term assets (NT$275.8M) do not cover its short term liabilities (NT$291.5M).
Long Term Liabilities: 6431's short term assets (NT$275.8M) exceed its long term liabilities (NT$153.3M).
Debt to Equity History and Analysis
Debt Level: 6431's net debt to equity ratio (18.9%) is considered satisfactory.
Reducing Debt: 6431's debt to equity ratio has increased from 0% to 33.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 6431 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 6431 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 14.4% each year